DermatologyResearch Phase

Melitane (Acetyl Hexapeptide-1)

Topical

Overview

Acetyl Hexapeptide-1 is a synthetic hexapeptide designed to stimulate melanin synthesis by acting as an agonist at melanocortin-1 receptors on melanocytes. The acetyl modification is intended to improve peptide stability and cellular permeability.

Mechanism of Action

Its therapeutic rationale is to promote tanning and photoprotection through increased melanogenesis, potentially offering a biomimetic alternative to UV exposure for pigmentation enhancement..

Research Summary & Key Findings

In vitro studies have shown increased tyrosinase activity and melanin content in melanocyte cultures. Small-scale human studies have reported modest increases in skin pigmentation without UV exposure, though safety data regarding long-term use and effects on melanocytic proliferation are limited.

Clinical Status

Research Phase

Melitane (Acetyl Hexapeptide-1) is in the research phase with limited clinical data in humans. Current evidence is primarily derived from preclinical (animal or in vitro) studies.

Administration Routes

Topical

Related Peptides in Dermatology

Find a Provider

Find a verified provider who offers Melitane (Acetyl Hexapeptide-1) therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Melitane (Acetyl Hexapeptide-1).

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.